By Diagnostics World Staff
October 14, 2015 | Kailos Genetics has announced the release of PGxComplete, a comprehensive, full panel, gene-based test offered at $99 through November 30, 2015. The Huntsville, Ala.-based company earlier announced a landmark effort with the HudsonAlpha Institute to offer free BRCA screening to 30-year-old women in Northern Alabama.
PGxComplete tests 20 different classes of medications to reveal how one’s body responds to more than 50 types of medications, including antidepressants, opioids, HIV/AIDS treatment and cancer therapy. By understanding how one’s body metabolizes these medicines, each person can take greater control over their own health, helping to avoid overdose, select the most effective medications and receive the desired results from treatment, the company said.
“It’s our goal to give people the ability to understand how medicine will work for them before it is prescribed,” said Troy Moore, chief scientific officer of Kailos Genetics, in a statement. “With full panel testing, people are able to see how they respond to a variety of medications catered to their lifestyle and needs. Whether someone is preparing for surgery, recovering from a heart attack or managing their cancer treatment, we want them to have the information necessary to make informed treatment decisions.”
A list of medicines tested through PGxComplete includes:
- Antiarrythmics: Digoxin, Flecainide and Propafenone
- Anticoagulants: Warfarin
- Antidepressants: Tri-cyclics, SSRIs and SNRIs
- Antidiabetics: Repaglinide
- Antiepileptics: Mephenytoin, Pheytoin and Valproic Acid
- Antihypertensives: Losartan and Metoprolol
- Chemotherapeutics: Capecitabine, Cisplatin, Cyclophosphamide, Fluorouracil, Methotrexate, Paclitaxel and Tamoxifen
- Corticosteroids: Prednisone
- HIV/AIDS Treatments: Efavirenz, Nelfinavir and NEvirapine
- Immunosuppressants: Cyclosporine, Mercaptourine, Sirolimus and Tacrolimus
- Muscle Relaxants: Carisoprodol and Diazapam
- NSAIDs, Celecoxib and Diclofenac
- Opioids: Buprenorphine, Codeine, Hydrocodone, Oxycodone and Tramadol
- Platelet Aggregation Inhibitors: Clopidogrel
- Proton Pump Inhibitors: Lansoprazole, Omeprazole and Pantoprazole
- Statins: Atorvastatin, Pravastain, Rosuvastatin and Simvastatin
- Thrombophilia: Risk factor for blood clot development